Hi Eire, I would like to know how our deal with Coroneo has gone? or has this been put on the back burner after ditching the valve repair trial.
The background work on Vax delivery methods and devices. What are they? and how will this be arranged for future trials. (This has been mentioned briefly via email)
Are we likely to see the hernia/pelvic floor product pushed back into the product line up?
And lastly, Patto mentioned a push into emerging markets.. Where exactly are these and how will this be achieved?
Hi Eire, I would like to know how our deal with Coroneo has...
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.30 |
Change
0.150(0.99%) |
Mkt cap ! $294.1M | |||
| Open | High | Low | Value | Volume |
| $15.35 | $15.35 | $15.00 | $92.29K | 6.09K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50 | $15.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.30 | 276 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |